Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study / Danese, S., Rudzinski, J., Brandt, W., Dupas, J.l., Peyrin-Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukas, M., Knutsson, M., Erlandsson, F., Hansen, M.b., Keshav, S.. - In: GUT. - ISSN 0017-5749. - 64:2(2015), pp. 243-249. [10.1136/gutjnl-2014-308004]